Loading...
Loading...
SCTL| Name | Value |
|---|---|
| Revenues | 21.2M |
| Cost of Revenue | 16.1M |
| Gross Profit | 5.1M |
| Operating Expense | 5.9M |
| Operating I/L | -0.9M |
| Other Income/Expense | -3.4M |
| Interest Income | 0.0M |
| Pretax | -4.3M |
| Income Tax Expense | 3.4M |
| Net Income/Loss | -7.7M |
Societal CDMO, Inc. is a contract development and manufacturing organization specializing in small molecule therapeutic development. The company offers end-to-end services including therapeutic development, regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging, and logistics for the global pharmaceutical market. It generates revenue by providing research and development, manufacturing, and packaging services for various therapeutic dosage forms, primarily focusing on small molecule therapeutic development.
